Nutritional Status in Adults With Diabetic Foot Ulcers
NutriDFU-P
4 other identifiers
observational
30
0 countries
N/A
Brief Summary
This feasibility and pilot study has two aims. The primary aim is to assess the feasibility of collecting clinical, nutritional, and functional data among adults with diabetic foot ulcers (DFUs) who are treated at an outpatient wound clinic. Specifically, the study will evaluate recruitment and inclusion rates, the relevance and clinical utility of selected variables, and assess the completeness and reliability of data collection. The secondary aim is to provide a preliminary characterisation of nutritional status, dietary intake, body composition, muscle strength, mobility, and wound-related quality of life, to inform the design and methodology of a future full-scale national study. DFUs are associated with delayed healing, recurrent infections, reduced quality of life, and increased risk of hospitalization and amputation. These conditions are frequently accompanied by systemic inflammation, impaired circulation, and metabolic disturbances, which may increase nutritional requirements and negatively affect wound healing. Despite nutrition being recognized as a modifiable factor of ulcer healing, the nutritional status of individuals with DFUs remains insufficiently characterised, and evidence regarding clinically relevant nutritional deficiencies in this population is limited. Participants will undergo assessment of height, weight, body composition, handgrip strength, and a 24-hour dietary recall interview during an outpatient clinic visit. Nutritional screening questionnaires and patient-reported measures of appetite, nutritional impact symptoms, mobility, and quality of life will be collected through telephone interviews within one week of the clinical visit. Eligible participants are adults (\>18 years) who are referred to the outpatient wound clinic with a hard-to-heal foot ulcer. Participants must be able to communicate in Danish or English.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2026
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 19, 2026
CompletedFirst Posted
Study publicly available on registry
June 2, 2026
CompletedStudy Start
First participant enrolled
June 2, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 30, 2026
June 2, 2026
May 1, 2026
4 months
May 19, 2026
May 29, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Feasibility of the data collection protocol
The primary outcome is the proportion of enrolled participants who complete all components of the data collection protocol, defined as: (1) completion of all anthropometric and functional assessments during the outpatient clinic visit, and (2) completion of the telephone interview within one week of the clinic visit. Both components must be completed for a participant to be counted as a completer. Results reported as a single proportion (%). A priori success threshold: ≥70% of enrolled participants complete all data collection components. If 40-69 % complete the data collection modifications are needed and if less that 40 % completion the study is not feasible in its current form. Unit of Measure: Percentage of eligible patients (%)
From inclusion to completion of telephone interview, approximately 1 week
Secondary Outcomes (11)
Recruitment rate
Duration of inclusion period, approximately 3 months
Completeness of individual variables
From inclusion to completion of telephone interview, approximately one week
Duration of clinic visit assessments
Measured at baseline clinical visit and telephone interview within one week
Telephone interview completion rate
Measured at baseline and telephone interview within one week
Participant acceptance and compliance
Measured at baseline clinic visit
- +6 more secondary outcomes
Other Outcomes (3)
Muscle strength
Measured at baseline clinic visit
Mobility and physical activity
Measured at telephone interview, within one week of clinic visit
Staff-reported feasibility
Following completion of inclusion period, approximately 3 months
Study Arms (1)
Single cohort: Adults with type 1 or type 2 diabetes and one or more active DFUs
The cohort receive treatment at the Wound Outpatient Clinic, Hvidovre Hospital. No intervention is administered as part of this study.
Interventions
The intervention consists of nutrition education and oral protein supplementation. Participants receive an information leaflet and brief guidance on protein intake for wound healing, along with an offer of a protein drink during outpatient visits.
Eligibility Criteria
Adult patients with non-healing diabetic foot ulcers (DFUs) receiving treatment at the outpatient clinic at Hvidovre Hospital.
You may qualify if:
- Age ≥ 18 years
- Diagnosed with diabetes type 1 or type 2
- Presence of one or more DFUs
- Receiving treatment in a participating outpatient wound clinic
- Able to provide written informed consent
You may not qualify if:
- Above ankle amputation of the contralateral leg
- Current treatment with intravenous antibiotics for acute infection.
- Current hospitalisation for acute surgical management of the foot ulcer
- Declining or unable to participate in a telephone follow-up interview.
- Current long-term enteral (tube feeding) or parenteral nutritional support.
- \- Presence of a cardiac pacemaker or other implanted electronic device
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hvidovre University Hospitallead
- The Novo Nordic Foundationcollaborator
- Copenhagen University Hospital, Hvidovrecollaborator
Related Publications (9)
Teresi JA, Yu X, Stewart AL, Hays RD. Guidelines for Designing and Evaluating Feasibility Pilot Studies. Med Care. 2022 Jan 1;60(1):95-103. doi: 10.1097/MLR.0000000000001664.
PMID: 34812790BACKGROUNDKnudsen JT, Johansen CW, Hansen AO, Eshoj HR. The Danish wound-quality of life (Wound-QoL) questionnaire: Translation and psychometric properties. Wound Repair Regen. 2021 Nov;29(6):973-984. doi: 10.1111/wrr.12957. Epub 2021 Jul 13.
PMID: 34255906BACKGROUNDPedersen MM, Kjaer-Sorensen P, Midtgaard J, Brown CJ, Bodilsen AC. A Danish version of the life-space assessment (LSA-DK) - translation, content validity and cultural adaptation using cognitive interviewing in older mobility limited adults. BMC Geriatr. 2019 Nov 15;19(1):312. doi: 10.1186/s12877-019-1347-0.
PMID: 31729972BACKGROUNDCederholm T, Jensen GL, Correia MITD, Gonzalez MC, Fukushima R, Higashiguchi T, Baptista G, Barazzoni R, Blaauw R, Coats A, Crivelli A, Evans DC, Gramlich L, Fuchs-Tarlovsky V, Keller H, Llido L, Malone A, Mogensen KM, Morley JE, Muscaritoli M, Nyulasi I, Pirlich M, Pisprasert V, de van der Schueren MAE, Siltharm S, Singer P, Tappenden K, Velasco N, Waitzberg D, Yamwong P, Yu J, Van Gossum A, Compher C; GLIM Core Leadership Committee; GLIM Working Group. GLIM criteria for the diagnosis of malnutrition - A consensus report from the global clinical nutrition community. Clin Nutr. 2019 Feb;38(1):1-9. doi: 10.1016/j.clnu.2018.08.002. Epub 2018 Sep 3.
PMID: 30181091BACKGROUNDTobberup R, Jager-Wittenaar H, Sorensen J, Kopp LHP, Svarstad P, Saetre P, Ottery FD. Translation and cultural adaptation of the scored Patient-Generated Subjective Global Assessment (PG-SGA(c)). Clin Nutr ESPEN. 2022 Feb;47:215-220. doi: 10.1016/j.clnesp.2021.12.012. Epub 2021 Dec 17.
PMID: 35063204BACKGROUNDDa Porto A, Miranda C, Brosolo G, Zanette G, Michelli A, Ros RD. Nutritional supplementation on wound healing in diabetic foot: What is known and what is new? World J Diabetes. 2022 Nov 15;13(11):940-948. doi: 10.4239/wjd.v13.i11.940.
PMID: 36437863BACKGROUNDMoore ZE, Corcoran MA, Patton D. Nutritional interventions for treating foot ulcers in people with diabetes. Cochrane Database Syst Rev. 2020 Jul 17;7(7):CD011378. doi: 10.1002/14651858.CD011378.pub2.
PMID: 32677037BACKGROUNDBarnes JA, Eid MA, Creager MA, Goodney PP. Epidemiology and Risk of Amputation in Patients With Diabetes Mellitus and Peripheral Artery Disease. Arterioscler Thromb Vasc Biol. 2020 Aug;40(8):1808-1817. doi: 10.1161/ATVBAHA.120.314595. Epub 2020 Jun 25.
PMID: 32580632BACKGROUNDArmstrong DG, Tan TW, Boulton AJM, Bus SA. Diabetic Foot Ulcers: A Review. JAMA. 2023 Jul 3;330(1):62-75. doi: 10.1001/jama.2023.10578.
PMID: 37395769BACKGROUND
Biospecimen
no samples are collected
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pia S Jensen, PhD
Outpatient clinic at the Department of Orthopedic Surgery, Hvidovre University Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PHD, Associate Professor
Study Record Dates
First Submitted
May 19, 2026
First Posted
June 2, 2026
Study Start
June 2, 2026
Primary Completion (Estimated)
September 30, 2026
Study Completion (Estimated)
October 30, 2026
Last Updated
June 2, 2026
Record last verified: 2026-05